DWT
VRTX icon

Dorsey & Whitney Trust’s Vertex Pharmaceuticals VRTX Stock Holding History

Dorsey & Whitney Trust’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.13M Sell
2,284
-36
-2% -$16K 0.06% 274
2026
Q1 		$1.04M Buy
2,320
+47
+2% +$21.9K 0.06% 279
2025
Q4 		$1.03M Sell
2,273
-80
-3% -$34.5K 0.05% 279
2025
Q3 		$922K Sell
2,353
-140
-6% -$58.5K 0.05% 296
2025
Q2 		$1.11M Sell
2,493
-207
-8% -$95.4K 0.06% 259
2025
Q1 		$1.31M Buy
2,700
+146
+6% +$68K 0.08% 223
2024
Q4 		$1.03M Buy
2,554
+229
+10% +$106K 0.06% 260
2024
Q3 		$1.08M Buy
2,325
+40
+2% +$19.2K 0.06% 245
2024
Q2 		$1.07M Sell
2,285
-79
-3% -$34.3K 0.07% 214
2024
Q1 		$988K Buy
2,364
+35
+2% +$14.8K 0.07% 221
2023
Q4 		$948K Sell
2,329
-16
-0.7% -$5.91K 0.07% 218
2023
Q3 		$815K Buy
2,345
+12
+0.5% +$4.2K 0.07% 221
2023
Q2 		$821K Buy
2,333
+774
+50% +$261K 0.07% 233
2023
Q1 		$491K Buy
1,559
+527
+51% +$158K 0.04% 307
2022
Q4 		$298K Sell
1,032
-121
-10% -$36.9K 0.03% 411
2022
Q3 		$334K Buy
1,153
+227
+25% +$65.3K 0.03% 374
2022
Q2 		$262K Sell
926
-86
-8% -$23K 0.03% 438
2022
Q1 		$265K Sell
1,012
-193
-16% -$45.8K 0.02% 461
2021
Q4 		$264K Buy
+1,205
New +$234K 0.02% 446
2021
Q2 		– Sell
-1,097
Closed -$237K – 549
2021
Q1 		$237K Buy
1,097
+40
+4% +$8.79K 0.02% 458
2020
Q4 		$250K Sell
1,057
-139
-12% -$31.9K 0.03% 394
2020
Q3 		$326K Buy
1,196
+46
+4% +$12.7K 0.04% 284
2020
Q2 		$333K Buy
1,150
+211
+22% +$57.2K 0.05% 290
2020
Q1 		$224K Buy
+939
New +$215K 0.04% 333

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Dorsey & Whitney Trust's VRTX Position: Q2 2026 in Review

Dorsey & Whitney Trust reduced its Vertex Pharmaceuticals (VRTX) stake by 1.6% in Q2 2026, selling an estimated $16K and leaving 2,284 shares worth $1.13M. The position accounts for 0.06% of the portfolio, ranked #274.

Dorsey & Whitney Trust first reported a position in VRTX in Q1 2020 and has held it in 24 quarters since. The position peaked at $1.31M in Q1 2025. 1,758 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Dorsey & Whitney Trust held 2,284 shares of Vertex Pharmaceuticals worth $1.13M as of Q2 2026.
  • Dorsey & Whitney Trust sold 36 Vertex Pharmaceuticals shares in Q2 2026, an estimated $16K.
  • Vertex Pharmaceuticals made up 0.06% of Dorsey & Whitney Trust's portfolio in Q2 2026, its #274 holding.
  • Dorsey & Whitney Trust first reported a position in Vertex Pharmaceuticals in Q1 2020 and has held it in 24 quarters since.
  • Dorsey & Whitney Trust's Vertex Pharmaceuticals position peaked at $1.31M in Q1 2025.
  • 1,758 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Dorsey & Whitney Trust's 13F filing for Q2 2026, filed 14 Aug 2026.